BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 33526524)

  • 21. Septic arthritis and osteomyelitis in a 10-year-old boy, caused by Fusobacterium nucleatum, diagnosed with PCR/16S ribosomal bacterial DNA amplification.
    Kroon E; Arents NA; Halbertsma FJ
    BMJ Case Rep; 2012 May; 2012():. PubMed ID: 22605875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Septic Arthritis of Native Joints.
    Ross JJ
    Infect Dis Clin North Am; 2017 Jun; 31(2):203-218. PubMed ID: 28366221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rituximab-induced interstitial lung disease in a patient with aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorder.
    Ahn SH; Kim SM; Sung JJ
    Mult Scler Relat Disord; 2018 Feb; 20():192-193. PubMed ID: 29414297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Course of neuromyelitis optica during inadvertent pregnancy in a patient treated with rituximab.
    Pellkofer HL; Suessmair C; Schulze A; Hohlfeld R; Kuempfel T
    Mult Scler; 2009 Aug; 15(8):1006-8. PubMed ID: 19667025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Posterior reversible encephalopathy syndrome masquerading as progressive multifocal leukoencephalopathy in rituximab treated neuromyelitis optica.
    Berger JR; Neltner J; Smith C; Cambi F
    Mult Scler Relat Disord; 2014 Nov; 3(6):728-31. PubMed ID: 25891552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A long-term follow-up of rituximab treatment in 20 Chinese patients with neuromyelitis optica spectrum disorders.
    Lu Q; Luo J; Hao H; Liu R; Jin H; Jin Y; Gao F
    Mult Scler Relat Disord; 2020 May; 40():101933. PubMed ID: 31955136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Native joint polyarticular septic arthritis secondary to disseminated
    El Zein S; Garvey T; Amin S; Tande AJ
    IDCases; 2023; 32():e01744. PubMed ID: 36949889
    [No Abstract]   [Full Text] [Related]  

  • 28. Ureaplasma urealyticum septic oligoarthritis in a patient with severe secondary hypogammaglobulinaemia.
    Bradhurst P; El-Haddad C; Ng J; Urriola N
    Med J Aust; 2021 Jun; 214(11):506-507.e1. PubMed ID: 34046899
    [No Abstract]   [Full Text] [Related]  

  • 29. Microbiology of acute arthropathies among children in Argentina: Mycoplasma pneumoniae and hominis and Ureaplasma urealyticum.
    Poggio TV; Orlando N; Galanternik L; Grinstein S
    Pediatr Infect Dis J; 1998 Apr; 17(4):304-8. PubMed ID: 9576384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation of Chlamydia trachomatis or Ureaplasma urealyticum from the synovial fluid of patients with Reiter's syndrome.
    Pavlica L; Drasković N; Kuljić-Kapulica N; Nikolić D
    Vojnosanit Pregl; 2003; 60(1):5-10. PubMed ID: 12688106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Post-arthroscopy septic arthritis: Current data and practical recommendations.
    Bauer T; Boisrenoult P; Jenny JY
    Orthop Traumatol Surg Res; 2015 Dec; 101(8 Suppl):S347-50. PubMed ID: 26412207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute hematogenous osteomyelitis and septic arthritis in children.
    Kao HC; Huang YC; Chiu CH; Chang LY; Lee ZL; Chung PW; Kao FC; Lin TY
    J Microbiol Immunol Infect; 2003 Dec; 36(4):260-5. PubMed ID: 14723255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CLINICAL CASE OF NEUROMYELITIS OPTICA SPECTRUM DISORDERS IN YOUNG WOMAN TREATED WITH RITUXIMAB.
    Poiasnyk IM; Gryb VA
    Wiad Lek; 2022; 75(1):132-137. PubMed ID: 35092262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial.
    Tahara M; Oeda T; Okada K; Kiriyama T; Ochi K; Maruyama H; Fukaura H; Nomura K; Shimizu Y; Mori M; Nakashima I; Misu T; Umemura A; Yamamoto K; Sawada H
    Lancet Neurol; 2020 Apr; 19(4):298-306. PubMed ID: 32199095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular diagnosis of Ureaplasma urealyticum in an immunocompetent patient with destructive reactive polyarthritis.
    Vittecoq O; Schaeverbeke T; Favre S; Daragon A; Biga N; Cambon-Michot C; Bébéar C; Le Loët X
    Arthritis Rheum; 1997 Nov; 40(11):2084-9. PubMed ID: 9365099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rituximab as first-line therapy in neuromyelitis optica: efficiency and tolerability.
    Zéphir H; Bernard-Valnet R; Lebrun C; Outteryck O; Audoin B; Bourre B; Pittion S; Wiertlewski S; Ouallet JC; Neau JP; Ciron J; Clavelou P; Marignier R; Brassat D
    J Neurol; 2015 Oct; 262(10):2329-35. PubMed ID: 26194198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A child with Erysipelothrix arthritis-beware of the little known.
    Mukhopadhyay C; Shah H; Vandana KE; Munim F; Vijayan S
    Asian Pac J Trop Biomed; 2012 Jun; 2(6):503-4. PubMed ID: 23569959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the current use of imaging modalities and pathogen detection in children with acute osteomyelitis and septic arthritis.
    Manz N; Krieg AH; Heininger U; Ritz N
    Eur J Pediatr; 2018 Jul; 177(7):1071-1080. PubMed ID: 29728840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolonged Remission in Neuromyelitis Optica Following Cessation of Rituximab Treatment.
    Weinfurtner K; Graves J; Ness J; Krupp L; Milazzo M; Waubant E
    J Child Neurol; 2015 Sep; 30(10):1366-70. PubMed ID: 25387545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteo-articular infections in newborns: diagnosis and treatment.
    Dessì A; Crisafulli M; Accossu S; Setzu V; Fanos V
    J Chemother; 2008 Oct; 20(5):542-50. PubMed ID: 19028615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.